Page last updated: 2024-08-23

bromocriptine and Ataxia

bromocriptine has been researched along with Ataxia in 2 studies

*Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Butler, DE; Coughenour, LL; DeWald, HA; Downs, DA; Heffner, TG; Lustgarten, D; Pugsley, TA; Wise, LD1
Mohanasundari, M; Sabesan, M; Sethupathy, S; Srinivasan, MS1

Other Studies

2 other study(ies) available for bromocriptine and Ataxia

ArticleYear
(5-Amino-1,3-dimethyl-1H-pyrazol-4-yl)(2-fluorophenyl)methanones . A series of novel potential antipsychotic agents.
    Journal of medicinal chemistry, 1986, Volume: 29, Issue:9

    Topics: Animals; Antipsychotic Agents; Apomorphine; Ataxia; Avoidance Learning; Brain; Cebus; Chemical Phenomena; Chemistry; Dopamine; Male; Mice; Motor Activity; Movement Disorders; Pyrazoles; Rats; Rats, Inbred Strains; Receptors, Dopamine; Saimiri

1986
Enhanced neuroprotective effect by combination of bromocriptine and Hypericum perforatum extract against MPTP-induced neurotoxicity in mice.
    Journal of the neurological sciences, 2006, Nov-15, Volume: 249, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Ataxia; Bromocriptine; Catalase; Corpus Striatum; Dopamine; Dopamine Agonists; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Glutathione; Glutathione Peroxidase; Hand Strength; Hypericum; Lipid Peroxidation; Locomotion; Male; Mice; MPTP Poisoning; Muscle Weakness; Neuroprotective Agents; Parkinsonian Disorders; Phytotherapy; Plant Extracts; Superoxide Dismutase

2006